(Q37362777)

19 August 2017

1 reference

title

Thiazolidinedione associated volume overload and pulmonary hypertension (English)

1 reference

19 August 2017

Jeffrey Michaelson

1

1 reference

19 August 2017

21 August 2008

1 reference

Therapeutic advances in cardiovascular disease

19 August 2017

1 reference

19 August 2017

2

1 reference

19 August 2017

6

1 reference

19 August 2017

435-438

1 reference

Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome

19 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093413

Pulmonary artery hypertension and sleep-disordered breathing: ACCP evidence-based clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093413

Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093413

Thiazolidinedione-induced edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093413

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093413

A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093413

Management of rosiglitazone-induced edema: two case reports and a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944708093413

21 January 2018

Identifiers

DOI

10.1177/1753944708093413

1 reference

19 August 2017

1 reference

PubMed ID

19124440